Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
ASX Announcements
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Investor Newsletters
Corporate Governance
Shareholder Services
Media Centre
Overview
Latest News
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
Media Centre
>
Latest News
Overview
Latest News
Video
Coverage
Latest News
Filter by Year:
2023
2022
2021
2020
1-Nov-2022
Edison report: Q1 23 cash flows in line with our estimates
28-Oct-2022
New melanoma breakthrough by Kazia could potentially save thousands of lives
10-Oct-2022
Edison report: PNOC022 trial expanded
5-Sep-2022
Edison report: Doubling down on clinical development
8-Aug-2022
Interim data from MSKCC study
1-Aug-2022
GBM Agile Update
20-Jul-2022
Kazia recognises GBM Awareness Day 2022 as it expands clinical trial activity in Europe and US
12-Jul-2022
Kazia launches new SAB
17-Jun-2022
FDA AWARDS ORPHAN DESIGNATION TO PAXALISIB FOR ATRT
14-Jun-2022
Kazia paxalisib preclinical DIPG data released at IPSNO
1
2
3
Next
